Acute and Short-Term Administration of a Sulfonylurea (Gliclazide) Increases Pulsatile Insulin Secretion in Type 2 Diabetes

Diabetes

Volumn 50, Issue 8, 2001, Pages 1778-1784

  Juhl, Claus B ^a,b,d   Pørksen, Niels ^a   Pincus, Steven M ^e   Hansen, Åge P ^b   Veldhuis, Johannes D ^c   Schmitz, Ole ^a,d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b KOLDING HOSPITAL   (Denmark)

^c UNIVERSITY OF VIRGINIA   (United States)

^d AARHUS UNIVERSITY   (Denmark)

^e Aarhus Kommunehospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; FATTY ACID; GLICLAZIDE; GLUCAGON; GLYCOSYLATED HEMOGLOBIN; INSULIN; PLACEBO;

ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; ENTROPY; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SECRETION; TIME;

BLOOD GLUCOSE; C-PEPTIDE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENTROPY; FATTY ACIDS, NONESTERIFIED; GLICLAZIDE; GLUCAGON; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MIDDLE AGED; PLACEBOS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0035430955     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.8.1778     Document Type: Article

References (34)

1. Goodner CJ, Walike BC, Koerker DJ, Ensinck JW, Brown AC, Chideckel EW, Palmer J, Kalnasy L: Insulin, glucagon and glucose exhibit synchronous, sustained oscillations in fasting monkeys. Science 195:177-179, 1977
2. Lang DA, Matthews DR, Peto J, Turner RC: Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med 301:1023-1027, 1979
3. Matthews DR, Naylor BA, Jones RG, Ward GM, Turner RC: Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes 32:617-621, 1983
4. Komjati M, Bratusch Marrain P, Waldhausl W: Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro. Endocrinology 118:312-319, 1986
5. Bratusch Marrain PR, Komjati M, Waldhausl WK: Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans. Diabetes 35:922-926, 1986
6. Schmitz O, Pedersen SB, Mengel A, Porksen N, Bak J, Moller N, Richelsen B, Alberti KG, Butler PC, Orskov H: Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects. Metabolism 43:842-846, 1994
7. Lang DA, Matthews DR, Burnett M, Turner RC: Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes 30:435-439, 1981
8. Polonsky KS, Given BD, Hirsch LJ, Tillil H, Shapiro ET, Beebe C, Frank BH, Galloway JA, Van Cauter E: Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318:1231-1239, 1988
9. O'Rahilly S, Turner RC, Matthews DR: Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318:1225-1230, 1988
10. Schmitz O, Porksen N, Nyholm B, Skjaerbaek C, Butler PC, Veldhuis JD, Pincus SM: Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM. Am J Physiol 272:E218-E226, 1997
11. Matthews DR, Lang DA, Burnett MA, Turner RC: Control of pulsatile insulin secretion in man. Diabetologia 24:231-237, 1983
12. Shapiro ET, Van Cauter E, Tillil H, Given BD, Hirsch L, Beebe C, Rubenstein AH, Polonsky KS: Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69:571-576, 1989
13. Porksen NK, Munn SR, Steers JL, Schmitz O, Veldhuis JD, Butler PC: Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass. Diabetes 45:1792-1797, 1990
14. Porksen N, Munn S, Steers J, Veldhuis JD, Butler PC: Effects of glucose ingestion versus infusion on pulsatile insulin secretion: the incretin effect is achieved by amplification of insulin secretory burst mass. Diabetes 45:1317-1323, 1996
15. Porksen N, Munn SR, Steers JL, Veldhuis JD, Butler PC: Effects of somatostatin on pulsatile insulin secretion: elective inhibition of insulin burst mass. Am J Physiol 270:E1043-E1049, 1996
16. Porksen N, Hussain MA, Bianda TL, Nyholm B, Christiansen JS, Butler PC, Veldhuis JD, Froesch ER, Schmitz O: IGF-I inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-I infusion rates. Am J Physiol 272:E352-E358, 1997
17. Porksen NK, Grøfte T, Nyholm B, Holst JJ, Pincus SM, Veldhuis JD, Schmitz O, Butler PC: Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion. Diabetes 47:45-49, 1998
18. Juhl CB, Porksen N, Hollingdal M, Sturis J, Pincus S, Veldhuis JD, Dejgaard A, Schmitz O: Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency. Diabetes Care 23:675-681, 2000
19. Juhl CB, Schmitz O, Pincus SM, Holst JJ, Veldhuis JD, Porksen NK: Short-term treatment with GLP-1 increases pulsatile insulin secretion in type II diabetes with no effect on orderliness. Diabetologia 43:583-588, 2000
20. Ashcroft FM, Gribble FM: ATP-sensitive K+ channels and insulin secretion: their role in health and disease. Diabetologia 42:903-919, 1999
21. Orskov H, Thomsen HG, Yde H: Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 219:193-195, 1968
22. Veldhuis JD, Carlson ML, Johnson ML: The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc Natl Acad Sci USA 84:7686-7690, 1987
23. Porksen NK, Nyholm B, Veldhuis JD, Butler PC, Schmitz O: In humans at least 75% of insulin secretion arises from punctuated secretory bursts. Am J Physiol 273:E908-E914, 1997
24. Chatfield C: The Analysis of Time Series: An Introduction. London, Chapman and Hall, 1996
25. Pincus SM: Approximate entropy as a measure of system complexity. Proc Natl Acad Sci U S A 88:2297-2301, 1991
26. Pincus SM, Hartman ML, Roelfsema F, Thorner MO, Veldhuis JD: Hormone pulsatility discrimination via coarse and short time-sampling. Am J Physiol 277:E948-E957, 1999
27. Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC: Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 38:767-772, 1989
28. Matthews DR, Boland O: The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state. Metabolism 46:5-9, 1997
29. Gregorio F, Ambrosi F, Cristallini S, Pedetti M, Filipponi P, Santeusanio F: Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function. Diabetes Res Clin Pract 18:197-206, 1992
30. Byrne MM, Gliem K, Wank U, Arnold R, Katschinski M, Polonsky KS, Goke B: Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Diabetes 47:1259-1265, 1998
31. Sturis J, Pugh WL, Tang J, Polonsky KS: Prevention of diabetes does not completely prevent insulin secretory defects in the ZDF rat. Am J Physiol 269:E786-E792, 1995
32. Mao CS, Berman N, Roberts K, Ipp E: Glucose entrainment of high-frequency plasma insulin oscillations in control and type 2 diabetic subjects. Diabetes 48:714-721, 1999
33. Porksen N, Juhl CB, Hollingdal M, Pincus SM, Sturis J, Veldhuis JD, Schmitz O: Concordant induction of rapid in vivo pulsatile insulin secretion by recurrent punctuated glucose infusions. Am J Physiol 278:E162-E170, 2000
34. Matthews DR, Hosker JP, Stratton I: The physiological action of gliclazide: beta-cell function and insulin resistance. Diabetes Res Clin Pract 14 (Suppl. 2):S53-S59, 1991